In summary, our study highlights Mettl3's role in CDDP-induced renal fibrosis, explains the underlying molecular mechanisms, and provides evidence that Mettl3 methyltransferase inhibition can both alleviate low-dose CDDP-induced renal fibrosis and enhance CDDP's tumor-killing efficiency. The gene discussed is METTL3; the disease is neoplasm.